Antibiotic Tolerance of Staphylococcus aureus Biofilm in Periprosthetic Joint Infections and Antibiofilm Strategies

Abstract

The need for bone and joint prostheses is currently growing due to population aging, leading to an increase in prosthetic joint infection cases. Biofilms represent an adaptive and quite common bacterial response to several stress factors which confer an important protection to bacteria. Biofilm formation starts with bacterial adhesion on a surface, such as an orthopedic prosthesis, further reinforced by matrix synthesis. The biofilm formation and structure depend on the immediate environment of the bacteria. In the case of infection, the periprosthetic joint environment represents a particular interface between bacteria, host cells, and the implant, favoring biofilm initiation and maturation. Treating such an infection represents a huge challenge because of the biofilm-specific high tolerance to antibiotics and its ability to evade the immune system. It is crucial to understand these mechanisms in order to find new and adapted strategies to prevent and eradicate implant-associated infections. Therefore, adapted models mimicking the infectious site are of utmost importance to recreate a relevant environment in order to test potential antibiofilm molecules. In periprosthetic joint infections, Staphylococcus aureus is mainly involved because of its high adaptation to the human physiology. The current review deals with the mechanisms involved in the antibiotic resistance and tolerance of Staphylococcus aureus in the particular periprosthetic joint infection context, and exposes different strategies to manage these infections.

Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant Staphylococcus aureus

“…Together with a higher antibiotic tolerance due to the low antibiotic permeability into the biofilm, it makes this biological structure a real barrier for the treatment of bacteria [ 4 ]. Biofilms made up of staphylococci are frequently involved in skin and soft-tissue infections, endocarditis, urinary tract and bone-related infections, and implant-related infections [ 40 ]. To this, it must be added that the presence of persister cells inside the biofilms is also related to chronic and relapsing infections [ 41 ], so activity on biofilms is a desired characteristic when developing new drugs.…”

Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing

“…Although biofilm production is a highly conserved mechanism in S. aureus, the composition and thickness of biofilms may differ among different strains (Kiedrowski et al, 2011;Vanhommerig et al, 2014). Methicillin-susceptible S. aureus (MSSA) and methicillinresistant S. aureus (MRSA) may behave differently during infection, forming biofilms of varying biomass through different pathways (Lamret et al, 2020). Biofilm formation in MSSA is usually dependent on polysaccharide intercellular adhesin or polymeric N-acetyl-glucosamine, whereas MRSA strains frequently produce biofilms with a more proteinaceous matrix (Pozzi et al, 2012;Vanhommerig et al, 2014).…”

The Effect of Vancomycin and Silver Combination on the Duration of Antibacterial Activity of Bone Cement and Methicillin-Resistant Staphylococcus aureusBiofilm Formation

“…Способность MRSA к адгезии и биопленкообразованию приводит к низкой эффективности лечения за счет устойчивости патогена к антибиотикам и факторам иммунной защиты организма [4]. Ключевым моментом является предупреждение формирования зрелой биопленки -иными словами, микробного очага.…”